Ethanol treats methanol poisoning by competing for the same enzyme that converts methanol into its toxic byproducts. Methanol itself is relatively harmless, but once your body begins breaking it down, it produces chemicals that can cause blindness, organ damage, and death. Ethanol occupies that enzyme so effectively that methanol passes through your body largely unprocessed and is eventually eliminated safely.
How Methanol Becomes Dangerous
When you ingest methanol, your liver processes it in three steps. First, an enzyme called alcohol dehydrogenase converts methanol into formaldehyde. Then formaldehyde is quickly converted into formic acid. Finally, formic acid is slowly broken down into carbon dioxide and water.
The problem is that third step. Your body breaks down formic acid far too slowly, so it accumulates in the blood. Formic acid is responsible for nearly all of methanol’s devastating effects: it causes severe metabolic acidosis (a dangerous drop in blood pH) and directly damages the optic nerve, which is why methanol poisoning is closely associated with blindness. Even small amounts of methanol can produce enough formic acid to be lethal if untreated.
Why Ethanol Blocks the Process
Alcohol dehydrogenase, the enzyme that kicks off the dangerous chain, doesn’t distinguish perfectly between different types of alcohol. It processes whichever alcohol molecule reaches it first. But it does have strong preferences. The enzyme binds ethanol far more readily than methanol. Depending on the specific form of the enzyme, its affinity for ethanol can be 10 to over 100 times greater than its affinity for methanol.
This means that when both ethanol and methanol are present in the bloodstream, the enzyme overwhelmingly chooses ethanol. Methanol molecules essentially get locked out. They remain in the blood as methanol, unconverted, and are gradually cleared by the kidneys and lungs without ever becoming formaldehyde or formic acid. This is called competitive inhibition: the two alcohols compete for the same enzyme, and ethanol wins.
Target Blood Levels for Treatment
For ethanol to keep alcohol dehydrogenase occupied, it needs to stay at a consistently high level in the blood. The target is typically between 100 and 150 mg/dL, which is well above the legal driving limit. This concentration must be maintained continuously until methanol levels drop below 20 mg/dL.
Reaching and holding that target is trickier than it sounds. When ethanol is given intravenously as a 10% solution, peak blood levels average around 104 mg/dL within about 45 minutes. When given orally (usually mixed into juice as a 20% solution), levels peak lower, around 71 mg/dL, and take roughly twice as long to get there. This means clinicians need to monitor blood ethanol levels frequently and adjust the infusion rate. The whole time, methanol is being cleared slowly. With ethanol treatment blocking metabolism, methanol’s half-life stretches to a median of about 43 hours, with a range of 30 to 52 hours. Treatment can last days.
Why Ethanol Isn’t Always the First Choice
A synthetic drug called fomepizole works the same way, blocking alcohol dehydrogenase, but without making the patient intoxicated. It has largely replaced ethanol in countries where it’s available. In the United States, fomepizole was used in over 1,700 cases of toxic alcohol ingestion in a single year compared to just 96 cases treated with ethanol. It’s given as a simple weight-based dose at fixed intervals, with no need to constantly check blood levels.
Ethanol, by contrast, requires intensive monitoring. A retrospective review found that adverse events occurred in 57% of ethanol-treated patients compared to 12% of those given fomepizole. The most common problem was central nervous system depression: patients became heavily sedated, sometimes requiring a breathing tube. About 4% of ethanol-treated patients developed low blood sugar, a known complication because ethanol disrupts glucose production in the liver. Fomepizole caused none of these metabolic side effects in the same review.
Despite these drawbacks, ethanol remains standard treatment in many hospitals worldwide. It costs a fraction of what fomepizole does, and physicians are familiar with how it works. In resource-limited settings or when fomepizole simply isn’t stocked, ethanol is a lifesaving alternative that’s nearly universally available.
When Ethanol Alone Isn’t Enough
Blocking the enzyme is only part of treatment. If formic acid has already accumulated before treatment begins, the damage is underway and needs to be addressed directly. Dialysis is recommended when blood pH drops below 7.25 to 7.30, when vision changes appear, when vital signs deteriorate despite supportive care, or when methanol levels exceed 50 mg/dL. Dialysis physically removes both methanol and formic acid from the blood far faster than the kidneys can. Even during dialysis, the target ethanol level is maintained at 100 to 150 mg/dL, because the enzyme still needs to be blocked while methanol remains in the body.
Treatment decisions typically begin when methanol blood levels exceed 20 to 25 mg/dL, though some guidelines use a higher threshold of 32 mg/dL if there’s no acidosis or organ damage yet. Another early clue is the osmolar gap, a calculated difference between expected and measured blood concentration. A gap above 50 strongly suggests toxic alcohol poisoning and can guide treatment even before specific methanol levels come back from the lab.
The Core Principle
The reason ethanol works comes down to a simple race. Your body has a limited number of enzyme molecules available to process alcohol. Ethanol binds to those molecules more tightly and more quickly than methanol does. As long as ethanol keeps the enzyme busy, methanol circulates harmlessly and is slowly excreted unchanged. The treatment doesn’t neutralize methanol or break it down. It just prevents your own metabolism from turning a mildly toxic substance into a lethal one.